Summary by Futu AI
On July 9, 2024, Mangoceuticals, Inc., also known as MangoRx, a NASDAQ-listed company specializing in men's health and wellness products, announced a Master Distribution Agreement with ISFLST, Inc. The agreement, which was officially signed on July 9 after being dated July 2, 2024, will enable ISFLST to distribute and resell MangoRx's products, including MangoRx Grow and Mango ED, in the Asia Pacific and Latin America regions, excluding Mexico. The partnership aims to leverage ISFLST's network to promote and sell MangoRx's products, with the potential for ISFLST to earn exclusive marketing rights in these markets upon meeting certain milestones. The distribution agreement has an initial term of three years, with automatic renewals for three additional one-year terms unless terminated. The...Show More